Seromycin Pulvules Interactions
There are 42 drugs known to interact with Seromycin Pulvules (cycloserine), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 12 are major, 29 are moderate, and 1 is minor.
- View all 42 medications that may interact with Seromycin Pulvules
- View Seromycin Pulvules alcohol/food interactions (1)
- View Seromycin Pulvules disease interactions (3)
Most frequently checked interactions
View interaction reports for Seromycin Pulvules (cycloserine) and the medicines listed below.
- acetaminophen / hydrocodone
- acetaminophen / oxycodone
- Actemra (tocilizumab)
- Adriamycin RDF (doxorubicin)
- Advate (antihemophilic factor)
- Adzenys XR-ODT (amphetamine)
- Alimta (pemetrexed)
- allopurinol
- Alphanate (antihemophilic factor/von willebrand factor)
- Alprolix (coagulation factor ix)
- Amevive (alefacept)
- Amicar (aminocaproic acid)
- amlodipine / hydrochlorothiazide / olmesartan
- Ansaid (flurbiprofen)
- AquADEKs (multivitamin with minerals)
- atorvastatin
- Duopa (carbidopa / levodopa)
- Feiba (anti-inhibitor coagulant complex)
- Inderal (propranolol)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- morphine
- Nydrazid (isoniazid)
- Onpattro (patisiran)
- Parsabiv (etelcalcetide)
- Sensipar (cinacalcet)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tecentriq (atezolizumab)
Seromycin Pulvules alcohol/food interactions
There is 1 alcohol/food interaction with Seromycin Pulvules (cycloserine).
Seromycin Pulvules disease interactions
There are 3 disease interactions with Seromycin Pulvules (cycloserine) which include:
Report options
QR code containing a link to this page
More about Seromycin Pulvules (cycloserine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: streptomyces derivatives
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.